The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Herbal products for liver diseases: A therapeutic challenge for the new millennium
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Milk Thistle (Silybum marianum) for the Therapy of Liver Disease
Flora, K. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(97)00082-8 · Cited by 746
Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver
Ferenci, P., Dragosics, B., Dittrich, H., Frank, H., Benda, L., Lochs, H., Meryn, S., Base, W., & Schneider, B. (1989) · Journal of Hepatology · doi:10.1016/0168-8278(89)90083-4 · Cited by 496
The long term efficacy of glycyrrhizin in chronic hepatitis C patients
Arase, Y., Ikeda, K., Murashima, N., Chayama, K., Tsubota, A., Koida, I., Suzuki, Y., Saitoh, S., Kobayashi, M., & Kumada, H. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970415)79:8<1494::aid-cncr8>3.0.co;2-b · Cited by 403
Parés, A., Planas, R., Torres, M., Caballería, J., Viver, J. M., Acero, D., Panés, J., Rigau, J., Santos, J., & Rodés, J. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80285-7 · Cited by 331
Silymarin protects against paracetamol‐induced lipid peroxidation and liver damage
Muriel, P., Garciapiña, T., Perez‐Alvarez, V., & Mourelle, M. (1992) · Journal of Applied Toxicology · doi:10.1002/jat.2550120613 · Cited by 301
EFFECT OF PHYLLANTHUS AMARUS ON CHRONIC CARRIERS OF HEPATITIS B VIRUS
Thyagarajan, S. P., Thirunalasundari, T., Subramanian, S. P., Venkateswaran, P. S., & Blumberg, B. S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92416-6 · Cited by 296
Boigk, G., Stroedter, L., Herbst, H., Waldschmidt, J., Riecken, E. O., & Schuppan, D. (1997) · Hepatology · doi:10.1002/hep.510260316 · Cited by 293
Self-citationDehmlow, C., Erhard, J., & de Groot, H. (1996) · Hepatology · doi:10.1002/hep.510230415 · Cited by 290
Venkateswaran, P. S., Millman, I., & Blumberg, B. S. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.274 · Cited by 280
Cited by
Plant-derived compounds in clinical trials
Saklani, A., & Kutty, S. K. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.010 · Cited by 477
Oxidative stress in viral and alcoholic hepatitis
Loguercio, C., & Federico, A. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01167-x · Cited by 424
Hepatic fibrosis: molecular mechanisms and drug targets
Lotersztajn, S., Julien, B., Teixeira-Clerc, F., Grenard, P., & Mallat, A. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095906 · Cited by 325
Targeting Liver Fibrosis: Strategies for Development and Validation of Antifibrotic Therapies†
Popov, Y., & Schuppan, D. (2009) · Hepatology · doi:10.1002/hep.23123 · Cited by 296
Self-citationComplementary and alternative medicine in chronic liver disease
Seeff, L. B., Lindsay, K. L., Bacon, B. R., Kresina, T. F., & Hoofnagle, J. H. (2001) · Hepatology · doi:10.1053/jhep.2001.27445 · Cited by 271
Metadata
- Authors
- Schuppan, D., Jia, J.-D., Brinkhaus, B., & Hahn, E. G.
- Venue
- Hepatology
- Published
- 1999-10
- Volume
- 30
- Issue
- 4
- Pages
- 1099-1104
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2086434450
- Cited by
- 279
- References
- 39
- FWCI
- 20.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Herbal products for liver diseases: A therapeutic challenge for the new millennium. https://app.cochat.ai/papers/10.1002/hep.510300437
- The paper
- Schuppan, D., Jia, J.-D., Brinkhaus, B., & Hahn, E. G. (1999). Herbal products for liver diseases: A therapeutic challenge for the new millennium. Hepatology. https://doi.org/10.1002/hep.510300437
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.